Maryland Senate Bill 778
Session 2026
Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
Became Law
Signed by Governor on Apr 28, 2026
Origin Chamber
Senate
Type
Bill
Bill Number
778
State
Maryland
Session
2026
checkPassed on March 5, 2026
Motion Text
On Third Reading
Senate Roll Call Votes
Didn't Vote
Absent
Yes
Yes
Absent
Yes
Guzzone
Yes
Yes
Yes
Absent
Yes
Yes
Yes
Mr. President
Yes
Yes
Yes
Smith
Yes
Watson
Yes
Absent
Summary
Unavailable
First - Clinical Research Pharmacies and Clinical Trials - Permits, Ownership, and Definition of Practice of Medicine
Third - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
Chapter - Clinical Research Pharmacies and Clinical Trials - Permits and Ownership
Fiscal and Policy Note (Revised)
Sort by most recent
04/28/2026
Office of the Governor
Approved by the Governor - Chapter 206
04/13/2026
Senate
Returned Passed
04/13/2026
House
Third Reading Passed
04/11/2026
House
Favorable Adopted Second Reading Passed
04/11/2026
House
Favorable Report by Health
03/25/2026
House
Hearing 4/02 at 1:00 p.m.
03/21/2026
House
Referred Health
03/20/2026
Senate
Third Reading Passed
03/19/2026
Senate
Second Reading Passed with Amendments
03/19/2026
Senate
Favorable with Amendments {
03/19/2026
Senate
Favorable with Amendments Report by Finance
02/12/2026
Senate
Hearing 3/03 at 1:00 p.m.
02/06/2026
Senate
First Reading Finance
Sources
Open States
Record Created
Mar 3, 2026 6:09:50 PM
Record Updated
May 5, 2026 11:26:56 PM